RYTM – Rhythm Pharmaceuticals Inc
Investors holding2
Combined shares364,974
Combined reported value$34.8M
RYTM chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Stanley Druckenmiller narrow view | 0.62 | Added 32.6% | 269,900 | $25.7M | Q3 2026 |
| Ray Dalio narrow view | 0.04 | New | 95,074 | $9.1M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Stanley Druckenmiller narrow view | Added 32.6% | 269,900 | 0.15 |
| Q3 2026 | Ray Dalio narrow view | New | 95,074 | 0.04 |
| Q2 2026 | Stanley Druckenmiller narrow view | New | 203,618 | 0.52 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Stanley Druckenmiller narrow view | Added 32.6% | 269,900 | 0.15 |
| Q3 2026 | Ray Dalio narrow view | New | 95,074 | 0.04 |
| Q2 2026 | Stanley Druckenmiller narrow view | New | 203,618 | 0.52 |
Reduced: reduced or closed
No tracked investor reduced or closed this position in the last 4 quarters.
History
2 peakQ3 2026: 2 tracked investors
20262026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Stanley Druckenmiller | 269.9K | 203.6K | – | – | – | – | – | – |
| Ray Dalio | 95.1K | – | – | – | – | – | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).